Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-145578

Dolby Laboratories, Inc. · DLB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Oct 6, 2016
Accepted (ET)
Oct 11, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockOct 6, 2016M20,249$28.66A137,370IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009
Class A Common StockF1Oct 6, 2016S20,249$55.0023D117,121IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009
Class A Common StockOct 7, 2016M1,701$28.66A118,822IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009
Class A Common StockOct 7, 2016S1,701$55.00D117,121IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009
Class A Common StockOct 10, 2016M152$28.66A117,273IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009
Class A Common StockOct 10, 2016S152$55.00D117,121IBy the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F2$28.66Oct 6, 2016M20,249D—Mar 16, 2019Class A Common Stock20,24989,508I
Employee Stock Option (right to buy)F2$28.66Oct 7, 2016M1,701D—Mar 16, 2019Class A Common Stock1,70187,807I
Employee Stock Option (right to buy)F2$28.66Oct 10, 2016M152D—Mar 16, 2019Class A Common Stock15287,655I

Explanation of responses

Remarks

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.